Markets finish week down after bouncing on Bannon's exit >>> READ MORE

3 Biotech Stocks That Could Keep Bombing

Many investors expect a rebound in biotechs and biotech ETFs like the IBB. But solid ground might be a ways lower from here.

      View All  

Biotech Stocks: Biogen (BIIB)

Click to Enlarge
Since 2010, Biogen (BIIB) has displayed an ever-steepening slope. If the slope had gotten any steeper in February, it would have had to lean back.

As I often point out, steep charts that go vertical almost always are eventually subject to relatively sharper corrections as gravity takes over and a mean-reversion move kicks in.

So far in this correction, BIIB stock has dropped just about 20% off the top, but the rising 200-day MA looms large about 7% lower and likely will act as a magnet in coming days or weeks.

Next Page

Article printed from InvestorPlace Media,

©2017 InvestorPlace Media, LLC